Abstract:
The CO VID -19 pandemic triggered a sharp contraction in economic activity, with GDP declining by 6.4% in 2020/21. However, it also spurred the unprecedented mobilization of R&D resources, particularly in health innovation, digital infrastructure, and crisis-responsive technologies. Despite this, growth in overall gross domestic expenditure on R&D (GERD ) remained fragile, with a modest recovery to 2.1% in 2022/23,
closely mirroring GDP growth of 1.9%. This recovery, however, masks underlying vulnerabilities, as pre-pandemic structural challenges—such as stagnant private-sector R&D investment and reliance on volatile public funding—persist.
Reference:
If you would like to obtain a copy of this Research Output, please contact the Research Outputs curators at researchoutputs@hsrc.ac.za
Attribution-NonCommercial
CC BY-NC
This license lets others remix, adapt, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.